Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study
Asnis, Gregory M, Bose, Anjana, Gommoll, Carl P, Chen, Changzheng, Greenberg, William M
Published in The journal of clinical psychiatry (01.03.2013)
Published in The journal of clinical psychiatry (01.03.2013)
Get more information
Journal Article
A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder
Sambunaris, Angelo, Bose, Anjana, Gommoll, Carl P, Chen, Changzheng, Greenberg, William M, Sheehan, David V
Published in Journal of clinical psychopharmacology (01.02.2014)
Published in Journal of clinical psychopharmacology (01.02.2014)
Get more information
Journal Article
Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials
Kornstein, Susan, Chang, Cheng-Tao, Gommoll, Carl P, Edwards, John
Published in International clinical psychopharmacology (01.07.2018)
Published in International clinical psychopharmacology (01.07.2018)
Get more information
Journal Article
Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials
Thase, Michael E, Edwards, John, Durgam, Suresh, Chen, Changzheng, Chang, Cheng-Tao, Mathews, Maju, Gommoll, Carl P
Published in International clinical psychopharmacology (01.09.2017)
Published in International clinical psychopharmacology (01.09.2017)
Get more information
Journal Article
Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study
Clayton, Anita H, Durgam, Suresh, Li, Dayong, Chen, Changzheng, Chen, Laishun, Mathews, Maju, Gommoll, Carl P, Szegedi, Armin
Published in International clinical psychopharmacology (01.01.2017)
Published in International clinical psychopharmacology (01.01.2017)
Get more information
Journal Article
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
Bakish, David, MD, Bose, Anjana, PhD, Gommoll, Carl, MS, Chen, Changzheng, PhD, Nunez, Rene, MD, Greenberg, William M, MD, Liebowitz, Michael, MD, Khan, Arif, MD
Published in Journal of psychiatry & neuroscience (2014)
Published in Journal of psychiatry & neuroscience (2014)
Get full text
Journal Article
Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial
Citrome, Leslie, Gommoll, Carl P, Tang, Xiongwen, Nunez, Rene, Mathews, Maju
Published in International clinical psychopharmacology (01.03.2015)
Published in International clinical psychopharmacology (01.03.2015)
Get more information
Journal Article
A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder
Gommoll, Carl P., Greenberg, William M., Chen, Changzheng
Published in Journal of drug assessment (London, U.K.) (01.01.2014)
Published in Journal of drug assessment (London, U.K.) (01.01.2014)
Get full text
Journal Article
Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
Durgam, Suresh, Chen, Changzheng, Gommoll, Carl P, Edwards, John, Citrome, Leslie
Published in Neuropsychiatric disease and treatment (01.01.2016)
Published in Neuropsychiatric disease and treatment (01.01.2016)
Get full text
Journal Article
Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition
Chen, Laishun, PhD, Greenberg, William M., MD, Gommoll, Carl, MS, O’Connor, Joann, PhD, Zukin, Stephen R., MD, Periclou, Antonia, PhD, Ghahramani, Parviz, PhD
Published in Clinical therapeutics (01.09.2015)
Published in Clinical therapeutics (01.09.2015)
Get full text
Journal Article
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder
Shiovitz, Thomas, Greenberg, William M, Chen, Changzheng, Forero, Giovanna, Gommoll, Carl P
Published in Innovations in clinical neuroscience (01.01.2014)
Get full text
Published in Innovations in clinical neuroscience (01.01.2014)
Journal Article
Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories
Cutler, Andrew J, Gommoll, Carl P, Chen, Changzheng, Greenberg, William M, Ruth, Adam
Published in Primary care companion for CNS disorders (2015)
Published in Primary care companion for CNS disorders (2015)
Get full text
Journal Article
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
Mathews, Maju, Gommoll, Carl, Chen, Dalei, Nunez, Rene, Khan, Arif
Published in International clinical psychopharmacology (01.03.2015)
Published in International clinical psychopharmacology (01.03.2015)
Get more information
Journal Article
Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial
Croft, Harry A, Pomara, Nunzio, Gommoll, Carl, Chen, Dalei, Nunez, Rene, Mathews, Maju
Published in The journal of clinical psychiatry (01.11.2014)
Published in The journal of clinical psychiatry (01.11.2014)
Get more information
Journal Article
Effects of Levomilnacipran ER on Noradrenergic Symptoms, Anxiety Symptoms, and Functional Impairment in Adults with Major Depressive Disorder: Post Hoc Analysis of 5 Clinical Trials
Blier, Pierre, Gommoll, Carl, Chen, Changzheng, Kramer, Kenneth
Published in Journal of affective disorders (01.03.2017)
Published in Journal of affective disorders (01.03.2017)
Get full text
Journal Article